Members only

Innovative technology for optimized arterial healing

The BioMatrixTM family favourably influences local wound healing processes.

Highly localised delivery of anti-restenotic BA9™ for at least six months.

Degradation of specifically designed PLA polymer to lactate, which has the potential to facilitate wound healing.
 

Specifically designed pro-healing polymer
Not all polymers are the same

  • Biosensors' PLA polymer degrades to naturally occuring Lactic Acid and Lactate
  • Lactate plays a key role in local arterial wound healing processes, mainly via enhanced Vascular Endothelial Growth Factor (VEGF) production6,7

 

The localized presence of PLA-derived lactate has the potential to facilitate arterial wound healing, including re-endothelialization6-7

 

11184-000-EN - Rev.03 + 10801-000-EN - Rev.05 + 11447-000-EN - Rev.01 + 11881-000-EN - Rev.04
BioMatrix NeoFlex™
Movie - How does it work?
Watch the working principle of our BioMatrix NeoFlex™ stent
BioMatrix NeoFlex™
Main brochure

BioMatrix NeoFlex™
Healing Journey brochure

BioMatrix NeoFlex™
Ordering information

6. Gladden LB. J Physiol. 2004;558(1):5-30
7. Ghani, QP. et al. Methods in Enzymology. 2004;381(36):565-75

 

BIOMATRIX™ FAMILY CLINICAL PROGRAM

CAUTION: Please note that the following pages are exclusively reserved for Health Care Professionals in countries with applicable health authority product registrations. To the extent this site contains information intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions. Please contact your Biosensors International representative for availability or the products and registration status.

The law restricts these devices to sale by or on the order of a physician. Prior to use, it is important to read the "Instructions for Use" supplied with these devices for indications, contraindications, suggested procedures, warnings, and precautions.

Biosensors’ interventional cardiology products, including BioMatrix NeoFlex™, BioMatrix™ Alpha, BioFreedom™, BioFreedom™ Ultra, BMX-J® and RISE™ NC, are not available for sale in the United States and certain other countries. ALLEGRA™ is a product of NVT GmbH. Blue Sail Medical Co., Ltd is the ultimate parent company of NVT GmbH and Biosensors International Group, Ltd. and its subsidiaries are collaborating for the commercialization of the ALLEGRA™ device.

BioMatrix NeoFlex, BioMatrix Alpha, BioFreedom, BioFreedom Ultra, BMX-J, Juno, S-Stent and Rise NC are trademarks or registered trademarks of Biosensors International Group, Ltd. ALLEGRA is a trademark or registered trademark of NVT AG. All other cited trademarks are the property of their respective owners.